Gannon Steven is a director of Fusion Pharmaceuticals Inc.
Person profile
Roles
Address
Burnaby, Alberta, Canada
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Xenon Pharmaceuticals Inc.
8 Mar 24
144
Xenon Pharmaceuticals Inc.
7 Mar 24
4
Fusion Pharmaceuticals Inc.
14 Jun 23
4
Xenon Pharmaceuticals Inc.
2 Jun 23
4
Fusion Pharmaceuticals Inc.
11 Aug 22
4
Xenon Pharmaceuticals Inc.
29 Jun 22
4
Fusion Pharmaceuticals Inc.
22 Jun 22
4
Fusion Pharmaceuticals Inc.
23 Aug 21
4
Fusion Pharmaceuticals Inc.
20 Aug 21
4
Fusion Pharmaceuticals Inc.
17 Aug 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Mar 24 | XENE Xenon Pharmaceuticals | Common Shares | Sell | Dispose S | No | No | 46.2012 | 2,000 | 92.40 k | 2,000 |
7 Mar 24 | XENE Xenon Pharmaceuticals | Common Shares | Sell | Dispose S | No | No | 46.3025 | 5,000 | 231.51 k | 4,000 |
7 Mar 24 | XENE Xenon Pharmaceuticals | Common Shares | Sell | Dispose S | No | No | 46.25 | 5,000 | 231.25 k | 9,000 |
7 Mar 24 | XENE Xenon Pharmaceuticals | Common Shares | Sell | Dispose S | No | No | 46.45 | 1,000 | 46.45 k | 14,000 |
14 Jun 23 | FUSN Fusion Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 4.64 | 17,000 | 78.88 k | 17,000 |
2 Jun 23 | XENE Xenon Pharmaceuticals | Stock Option Common Shares | Grant | Acquire A | No | No | 38.96 | 18,475 | 719.79 k | 18,475 |